Crispr Therapeutics Editas Medicine: Better Buy in 2026?
Two top gene-editing names, two very different strategies. This guide breaks down CRISPR Therapeutics and Editas Medi...
Explore year-end ETF Tax-Loss Harvesting ideas to harvest losses before year-end, diversify replacements, and sharpen tax efficiency.
24,551 articlesTwo top gene-editing names, two very different strategies. This guide breaks down CRISPR Therapeutics and Editas Medi...
Meta Platforms has built immense value on advertising, but a subscription-based approach could balance revenue stream...
A potential hawkish shift in monetary policy could derail the AI stock surge, threatening lofty earnings multiples fo...
Sam Valverde says valverde: pulte’s role won’t derail GSE reform as markets digest Bill Pulte's surprise DNI appointm...
Marvell Technology’s shares extend a rally after Nvidia CEO Jensen Huang praised the company as a potential trillion-...
Meta launches a $3.99 monthly Instagram Plus plan, delivering longer stories and advanced metrics as part of a broade...
Wisconsin announced a $10 million settlement with Tyco Fire Products over decades of PFAS contamination near Marinett...
Modernize your rental business with smart tools. This guide shows practical upgrades, a simple 90-day plan, and real-...
The Nasdaq Composite climbed again as semiconductors rebound and AI-driven demand steadies, signaling a renewed risk-...
Google has struck a major AI compute deal with SpaceX, paying about $920 million per month from late 2026 through mid...
A wave of at-home red light therapy devices is gaining traction as Americans weigh costs and potential skincare and r...
The Council of MLS Services appointed Jessica Edgerton as the next CEO, with a start date of July 1, 2026. The move e...